跳转到主要内容
搜索
会议

2026 ISPE 年会

Conference: 2026 ISPE 年会

日期： August 29 - 2026 年 9 月 2 日

地点： Milan, Italy

展位： 406

Learn more about Certara’s innovative approach to studying rare diseases

Addressing the complex challenges of rare disease drug development and evidence generation requires an innovative approach. Visit Certara at booth #406 at the 2026 ISPE Annual Meeting to connect with our real-world evidence and pharmacoepidemiology experts and learn how we’re linking rare disease registries with national health claims databases to overcome issues related to limited and incomplete data to help our customers assess the burden of illness.

Linking data to solve common yet complex challenges in studying rare disease

Certara’s experts help you overcome:

  • Limited data caused by inherently small patient populations
  • Fragmented, hard-to-find patients dispersed patient populations
  • Incomplete data sources that capture some outcomes and resource utilization but lack granular clinical measures or quality of life data

More information on posters and presentations coming soon

Explore Certara's RWE Services

  • Outcomes Research and Surveys: Analyzing treatment patterns, patient outcomes, and unmet needs in niche populations to inform development and market access strategies
  • Data Source Selection: Identifying and selecting the most appropriate real-world data sources (e.g., patient registries, medical records, claims data) to address specific research questions
  • Advanced Analytics and Modeling: Applying sophisticated analytical techniques to RWE to extract meaningful insights, including comparative effectiveness studies, cost-effectiveness analyses, and safety evaluations.
  • Regulatory Support: Providing regulatory writing, strategy, and submission expertise to support rare disease drug approvals.
  • Market Access Strategies: Developing strategies to optimize pricing, reimbursement, and market access for rare disease therapies.

Additional Resources

精选推荐

Building IND-Ready and Investor-Ready Development Programs
Building IND-Ready and Investor-Ready Development ProgramsWebinar

Building IND-Ready and Investor-Ready Development Programs

Certara Reappointed for a European Medicines Agency Contract, Expanding Opportunities to Shape the Future of Real-World Evidence for Regulatory Decision-Making
Certara Reappointed for a European Medicines Agency Contract, Expanding Opportunities to Shape the Future of Real-World Evidence for Regulatory Decision-MakingAnnouncement

Certara Reappointed for a European Medicines Agency Contract, Expanding Opportunities to Shape the Future of Real-World Evidence for Regulatory Decision-Making

How interactive value communication tools strengthen the value proposition in healthcare
How interactive value communication tools strengthen the value proposition in healthcareBlog

How interactive value communication tools strengthen the value proposition in healthcare

沪ICP备2022021526号
Powered by Translations.com GlobalLink Web Software